Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder

Neurochemical Research

Volumn 37, Issue 8, 2012, Pages 1761-1767

  Talarowska, Monika ^a   Gałecki, Piotr ^a   Maes, Michael ^b   Bobińska, Kinga ^a   Kowalczyk, Edward ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Piyavate Hospital   (Thailand)

Author keywords

Cognitive impairment; Depression; Inflammation; Total antioxidant status

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DECLARATIVE MEMORY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; TOTAL ANTIOXIDANT STATUS; WORKING MEMORY;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MEMORY, LONG-TERM; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; VERBAL LEARNING;

EID: 84864356863     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0788-z     Document Type: Article

References (40)

1. Audenaert LohorteP, Brans B, Van Laere K, Goethals I, van Heeringen K et al (2001) The classical Stroop interference task as a prefrontal activation probe: a validation study using 99Tc000-ECD brain SPECT. Nucl Med Commun 22:135-143
2. Bartosz G (2004) Other face of oxygen. PWN, Warsaw
3. Benzie I, Strain J (1999) Ferric reducing/antioxidant power assay: antioxidant activity of biological fluids and modified version for simultaneous measurement of total power and ascorbic acid concentration. Methods Enzymol 299:15-27
4. Benzie I, Strain J (1996) The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 239:70-76
5. Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B et al (2011) Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 7:12889-12899
6. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C et al (2006) Elevated protein-bound levels of the lipid peroxidation product 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 397:170-173
7. Clausen A, Doctrow S, Baudry M (2008) Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol Aging 31:425-433
8. Considine CM, Weisenbach SL, Walker SJ, McFadden EM, Franti LM, Bieliauskas LA et al (2011) Auditory memory decrements, without dissimulation, among patients with major depressive disorder. Arch Clin Neuropsychol 26:445-453
9. Cruz-Sánchez FF, Gironès X, Ortega A, Alameda F, Lafuente JV (2010) Oxidative stress in Alzheimer's disease hippocampus: a topographical study. J Neurol Sci 299:163-167
10. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R (2009) Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 63:639-645
11. Demyttenaere K, De Fruyt J (2003) Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 72:61-70
12. Floyd RA, Towner RA, He T, Hensley K, Maples KR (2011) Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med 51:931-941
13. Fuchs E, Flügge G (2002) Social stress in tree shrews: effect on physiology, brain function and behavior of subordinate individuals. Pharmacol Biochem Behav 73:247-258
14. Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E (2009) Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol 24:277-286
15. Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E (2009) Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 61:436-447
16. Gironi M, Bianchi A, Russo A, Alberoni M, Ceresa L, Angelini A et al (2011) Oxidative imbalance in different neurodegenerative diseases with memory impairment. Neurodegener Dis 8:129-137
17. Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M et al (2006) Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27:262-269
18. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56-62
19. ICD-10 (1993) Classification of Mental and Behavioural Disorders. World Health Organization, Geneva
20. Insel KC, Moore IM, Vidrine AN, Montgomery DW (2011) Biomarkers for cognitive aging-part II: oxidative stress, cognitive assessments, and medication adherence. Biol Res Nurs. doi: 10.1177/1099800411406527
21. Kaymak SU, Demir B, Sentürk S, Tatar I, Aldur MM, Uluǧ B (2010) Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders. Eur Arch Psychiatry Clin Neurosci 260:217-223
22. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA (2008) Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 10:1-37
23. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S (2011) Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 35:1284-1290
24. Łuria A (1976) Neuropsychology. PZWL, Warsaw
25. Lyche P, Jonassen R, Stiles TC, Ulleberg P, Landrø NI (2011) Verbal memory functions in unipolar major depression with and without co-morbid anxiety. Clin Neuropsychol 25:359-375
26. Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35(3):676-692
27. Malykhin NV, Carter R, Seres P, Coupland NJ (2010) Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci 35: 337-343
28. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L (2010) Cognitive impairment in major depression. Eur J Pharmacol 626:83-86
29. McDowd J, Hoffman L, Rozek E, Lyons KE, Pahwa R, Burns J et al (2011) Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease. Neuropsychol 25(2):210-225
30. Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K et al (2001) Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neurosci 107:415-431
31. Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA et al (2007) Neuronal death and survival under oxidative stress in Alzheimer disease. CNS Neurol Disord: Drug Targets 6:411-423
32. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469:6-10
33. Patten S (1997) Performance of the composite international diagnostic interview short Form for major depression in community and clinical samples. Chronic Dis Can 3:18-24
34. Sánchez-Cubillo I, Periáñez J, Adrover-Roig D, Rodríguez-Sánchez J, Ríos-Lago M, Tirapu J (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 15:438-451
35. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 22:67-73
36. Sekler A, Jiménez JM, Rojo L, Pastene E, Fuentes P, Slachevsky A et al (2008) Cognitive impairment and Alzheimer's disease: links with oxidative stress and cholesterol metabolism. J Neuropsychiatric Dis Treat 4:715-722
37. Talarowska M, Florkowski A, Zboralski K, Berent D, Wierzbiński P, Gałecki P (2010) Auditory-verbal declarative and operating memory among patients suffering from depressive disorders-preliminary study. Adv Med Sci 55:317-327
38. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL et al (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alz Dis 26:59-68
39. Uysal N, Tugyan K, Aksu I, Ozbal S, Ozdemir D, Dayi A et al (2012) Age-related changes in apoptosis in rat hippocampus induced by oxidative stress. J Biotech Histochem 87(2):98-104
40. Videbech P, Ravnkilde B (2004) Hippocampal volume and depression:a meta-analysis of MRI studies. Am J Psych 161:1957-1966